{
  "chemical_disease_relation_menu": [{
    "id": "1",
    "text": "(chemical) relates to disease",
    "desc": "The chemical has some type of relation to the disease.",
    "example": "",
    "children": [{
        "id": "1-2",
        "text": "Exacerbates",
        "desc": "The chemical worsens or exacerbates the disease in any manner.",
        "example": "",
      }, {
        "id": "1-1",
        "text": "Treats",
        "desc": "The chemical improves or treats the disease in any manner.",
        "example": "",
        "children": [{
          "id": "1-1-1",
          "text": "Treats the symptoms of",
          "desc": "Symptoms are defined as subjective physical or mental manifestations of a disease; examples include stomachache, lower-back pain, and fatigue. Signs are defined as objective manifestations of a disease; examples include high white blood cell count or bloody stool.",
          "example": "",
          }, {
          "id": "1-1-2",
          "text": "Treats the cause of",
          "desc": "Causes of disease include infectious, non-communicable/non-transferable, or lifestyle causes.",
          "example": "Artificial tears improve dry and itchy eyes in alacrima patients."
        }]
      }, {
        "id": "1-3",
        "text": "Increases risk of disease",
        "desc": "Administration of the drug increases chances of getting the disease. Considered an 'adverse side effect' of the drug.",
        "example": "Parkinson's disease risk factors include ageing, exposure to toxins and genetic defects.",
      }, {
        "id": "1-4",
        "text": "May cause",
        "desc": "Administration of the chemical may cause or lead to the disease.",
        "example": "43% of mice given the chemical NVP-BHG712 developed pulmonary metastases.",
      }, {
        "id": "1-5",
        "text": "prevents",
        "desc": "Administration of the chemical prevents the disease",
        "example": "Here, we demonstrate for the first time that treatment with gingerol prevents prion peptide-mediated neuronal cell death. This study suggests that treatment with gingerol may provide a novel therapeutic strategy for prion-mediated neurotoxicity",
      }]
    }, {
    "id": "2",
    "text": "has no relation to",
    "desc": "There is no relation between the chemical and disease.",
    "example": "To study soft tissue sarcoma, an experimental group of mice was given the chemical NVP-BHG712.",
  }],

  "gene_disease_relation_menu": [{
    "id": "1",
    "text": "(gene) relates to the disease",
    "desc": "The gene is related to the disease in some manner.",
    "example": "The gene responsible for Triple A syndrome, AAAS, has recently been identified.",
    "children": [{
      "id": "1-1",
      "text": "Altered expression is associated with",
      "desc": "Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product (mRNA, protein, or microRNAs). When gene expression is altered, gene expression is either increased or decreased.",
      "example": "Several studies revealed significantly higher EPHB4 expression in malignancies such as prostate cancer and colorectal cancer.",
      }, {
      "id": "1-3",
      "text": "Mutation is associated with",
      "desc": "Gene mutations or aberrations are permanent changes in the gene DNA sequence, differing from the sequence found in most people. Mutations range in size; they can affect anywhere from a single DNA base pair to a large piece of a chromosome that includes multiple genes.",
      "example": "Mutations in the COL5A or COL3A genes are only a few of the genetic causes of Ehlers-Danlos syndrome.",
      }, {
        "id": "1-4",
        "text": "And post-translational modifications are associated with",
        "desc": "Translation is protein synthesis. When changes are made to a protein during or after translation, it is considered a post-translational modification.",
        "example": "A small interfering RNA causes knockdown of ATP2C1 expression, resulting in defects in both post-translational processing of wild-type thyroglobulin",
    }]}, {
    "id": "2",
    "text": "Has no relation to",
    "desc": "The gene does not relate to the disease.",
    "example": "TODO"
  }],

  "gene_chemical_relation_menu": [{
    "id": "1",
    "text": "(gene) relates to the chemical",

    "children": [{
      "id": "1-1",
      "text": "amount is changed by",

      "children": [{
        "id": "1-1-1",
        "text": "expression is decreased by"
      }, {
        "id": "1-1-2",
        "text": "expression is increased by"
      }]

    }, {
      "id": "1-2",
      "text": "activity is changed by",

      "children": [{
        "id": "1-2-1",
        "text": "activity is inhibited by"
      }, {
        "id": "1-2-2",
        "text": "activity is activated by"
      }]
    }]

    }, {
    "id": "2",
    "text": "has no relation to"
    }
  ]



}
